Schedule
The final ISCT 2019 program is now available! View the final program..
Registered already for ISCT 2019? View the agenda and bookmark sessions within the ISCT 2019 Partnering System & App.
Not Registered? Register Now.
Wednesday
2019-05-29
Thursday
2019-05-30
Friday
2019-05-31
Saturday
2019-06-01
Wednesday
2019-05-29
08:00
- 08:30
Welcome and Regulatory Roundup (GRP Workshop)
Dominic Wall, PhD
Director of Pathology Operations, Peter MacCallum Cancer Center, Australia
08:30
- 10:00
Collection of Starting Product Before Cell Processing and Production (Cell Processing Track)
Mara Neal, SH(ASCP)MT, MS, MBA
Director, Cook Regentec
Vicki Antonenas, BSc, MSc
Scientific Director, Westmead Hospital
Haematologist and Blood and Marrow Transplant Physician, Westmead Hospital, Australia
Kenneth P. Micklethwaite, MBBS, PhD, FRACP, FRCPA
Haematologist and Blood and Marrow Transplant Physician, Westmead Hospital, Australia
CAR T -Cell Project Manager - Cell Therapies/Peter MacCallum Cancer Centre, Australia
Sharlea Disney
CAR T -Cell Project Manager - Cell Therapies/Peter MacCallum Cancer Centre, Australia
Wen Bo Wang, PhD
Senior Vice President, Technical Operations, Fate Therapeutics
08:30
- 10:00
Clinical Trials Part I: MSC Sources, Applications and ‘Off the Shelf’ Products (MSC Workshop)
Paul J. Simmons, PhD
Research & New Product Development, Mesoblast
Igor Slukvin, MD, PhD
Professor, University of Wisconsin-Madison, United States
Robert W. Mays, PhD
VP Regenerative Medicine and Head of Neuroscience Programs, Athersys, USA
08:30
- 10:00
Quality Plans and Document Control (ISCT-FACT Quality Bootcamp)
Patrick Hanley, PhD
Director, GMP for Immunotherapy Children's National Medical Center, USA
Guy Klamer, PhD
Quality Manager, Sydney Cord Blood Bank, Australia
08:30
- 10:00
CMC Considerations (including testing) for Pediatric Treatments & Case Study (Global Regulatory Perspectives)
Associate Professor, Obstetrics & Gynaecology, Monash University, Australia
Rebecca Lim, PhD (Moderator)
Associate Professor, Obstetrics & Gynaecology, Monash University, Australia
Ieva Ozolins, MD
Medical Advisor, TGA, Australia
Yoshiaki Maruyama, PhD
Review Director, Pharmaceuticals and Medical Devices Agency (PMDA), Japan
Mo Heidaran, PhD
VP Technical, PAREXEL, USA
08:30
- 10:00
Cord Blood Expansion (Cord Blood Series)
Director, Carolinas Cord Blood Bank Duke University Medical Center, United States
Joanne Kurtzberg, MD
Director, Carolinas Cord Blood Bank Duke University Medical Center, United States
Colleen Delaney, MD
Founder and Chief Scientific Officer, Nohla Therapeutics
Chief: Stem Cell Transplantation and Cellular Therapies, Memorial Sloan Kettering, USA
Jaap Boelens, MD, PhD
Chief: Stem Cell Transplantation and Cellular Therapies, Memorial Sloan Kettering, USA
10:00
- 10:15
Coffee Break
10:15
- 11:45
Cord Blood for Neurological Disorders (Cord Blood Series)
Director, Carolinas Cord Blood Bank Duke University Medical Center, United States
Joanne Kurtzberg, MD
Director, Carolinas Cord Blood Bank Duke University Medical Center, United States
Professor of Pediatrics, Samsung medical Center, Sungkyunkwan University, School of Medicine
Won Soon Park MD, PhD
Professor of Pediatrics, Samsung medical Center, Sungkyunkwan University, School of Medicine
MinYoung Kim MD, PhD
Professor, CHA University
10:15
- 11:15
Risk Assessment for Administration of Non-conforming Products & Case Study (Global Regulatory Perspectives)
Haematologist & Head of Allogeneic Stem Cell Transplantation, The Royal Melbourne Hospital, Australia
David Ritchie, Prof., MD, PhD (Moderator)
Haematologist & Head of Allogeneic Stem Cell Transplantation, The Royal Melbourne Hospital, Australia
Steven Oh, PhD
Deputy Director, Office of Tissues and Advanced Therapies, FDA, USA
Stephan Kadauke, MD, PhD
Assistant Director, Cell and Gene Therapy Lab, CHOP, USA
10:15
- 11:45
Specialized Cell Processing (Cell Processing Track)
Ruud Hulspas, PhD
Vice President Scientific Affairs, Cellular Therapies Bioconsulting, LLC
Professor of Oncology and Director, Departmet of Flow & Image Cytometry, Roswell Park Comprehensive Cancer Center
Paul Wallace, PhD
Professor of Oncology and Director, Departmet of Flow & Image Cytometry, Roswell Park Comprehensive Cancer Center
Leela L. Paris, PhD
Global Product Manager, Cook Regentec, United States
Frances Harding, PhD
Cell Therapies Specialist/Project Lead, Cell Therapies Pty. Ltd
Director, Cell GMP Facility, University of North Carolina Chapel-Hill, United States
Paul Eldridge, PhD
Director, Cell GMP Facility, University of North Carolina Chapel-Hill, United States
10:15
- 11:45
Clinical Trials Part II: Asia Pacific Spotlight (MSC Workshop)
Oscar K. Lee, MD, PhD
Chair Professor, National Yang-Ming University, Taiwan
Pawan Kumar Gupta, MBBS, MD, DNB, PhD
Senior Director Medical Services, Stempeutics Research
Professor, Center for stem cell biology and tissue engineering, Sun Yat-sen University
Andy Peng Xiang, PhD
Professor, Center for stem cell biology and tissue engineering, Sun Yat-sen University
Director of both Treatment and Research Center for Infectious Diseases and The Institute of Translational Hepatology, Beijing 302 Hospital
Fusheng Wang, MD, PhD,
Director of both Treatment and Research Center for Infectious Diseases and The Institute of Translational Hepatology, Beijing 302 Hospital
10:15
- 11:45
Stem Cell Crystal Ball – Navigating Contemporary Practice and Imagining the Future
Megan Munsie, PhD
Deputy Director, Centre for Stem Cell Systems, University of Melbourne, Australia
Royal Melbourne Hospital and the Walter and Eliza Hall Institute of Medical Research
Ashley Ng, MBBS, FRACP, FRACP Haem
Royal Melbourne Hospital and the Walter and Eliza Hall Institute of Medical Research
Rosa McCarty, PhD, GCUT
University of Melbourne
10:15
- 11:45
Performing Risk Assessment, What Now? (ISCT-FACT Quality Bootcamp)
11:45
- 01:00
Experimental Rigor in Phenotyping and Functional Testing by Flow Cytometry (Industry Luncheon Hosted By Beckman Coulter) (Cell Processing Track)
11:45
- 01:00
Next Generation MSC Technologies (Industry Luncheon Hosted By RoosterBio Inc.)
11:45
- 13:00
Lunch
12:45
- 14:30
Clinical Strategies for Treatment of Pediatric Diseases & Case Study (Global Regulatory Perspectives)
Director of Pathology Operations, Peter MacCallum Cancer Center, Australia
Dominic Wall, PhD (Moderator)
Director of Pathology Operations, Peter MacCallum Cancer Center, Australia
I-Ning Tang, MD
Section Chief of Regulatory Science, Taiwan Center for Drug Evaluation, Taiwan
Chief: Stem Cell Transplantation and Cellular Therapies, Memorial Sloan Kettering, USA
Jaap Boelens, MD, PhD
Chief: Stem Cell Transplantation and Cellular Therapies, Memorial Sloan Kettering, USA
Rachel Witten, MD
Lead Medical Officer, FDA, USA
13:00
- 14:30
MSC Regulatory Landscape (MSC Workshop)
Affiliate Scientist, Cell Therapy Program, University Health Network, Canada
Sowmya Viswanathan, PhD
Affiliate Scientist, Cell Therapy Program, University Health Network, Canada
Head, Division of Cell-Based Therapeutic Products, National Institute of Health Sciences
Yoji Sato, PhD
Head, Division of Cell-Based Therapeutic Products, National Institute of Health Sciences
Willem E. Fibbe, MD, PhD
Professor, Leiden University Medical Center
Tony Manderson, PhD
Head, Cell & Tissue Therapies Unit, TGA
13:00
- 14:30
Product Testing and Characterization by Flow Cytometry – A Joint Session with the International Society for Advancement of Cytometry (Cell Processing Track)
Ruud Hulspas, PhD
Vice President Scientific Affairs, Cellular Therapies Bioconsulting, LLC
Professor of Oncology and Director, Departmet of Flow & Image Cytometry, Roswell Park Comprehensive Cancer Center
Paul Wallace, PhD
Professor of Oncology and Director, Departmet of Flow & Image Cytometry, Roswell Park Comprehensive Cancer Center
Associate Professor, University of Melbourne; Peter MacCallum Cancer Centre, Australia
Paul Neeson, PhD
Associate Professor, University of Melbourne; Peter MacCallum Cancer Centre, Australia
13:00
- 14:30
ISCT Chief Scientific Officer Emerging Technologies Showcase
Daniel J. Weiss
Professor of Medicine, University of Vermont College of Medicine
Professor and Chair, Department of Anatomy & Cell Biology, University of Pennsylvania
Songtao Shi, DDS, MS, PhD
Professor and Chair, Department of Anatomy & Cell Biology, University of Pennsylvania
Professor Stem Cell Biology and Regenerative Medicine, The University of Adelaide
Stan Gronthos, PhD
Professor Stem Cell Biology and Regenerative Medicine, The University of Adelaide
Masayo Takahashi, MD, PhD
Project Leader, Retinal Renegeration Laboratory, RIKEN Center, Japan
13:00
- 14:30
Cord Blood Cellular Therapy (Cord Blood Series)
Professor, Children's National Medical Center & George Washington University, USA
Catherine Bollard, MD
Professor, Children's National Medical Center & George Washington University, USA
Professor of Medicine, University of Texas MD Anderson Cancer Research Center
Katy Rezvani, MBBS, PhD
Professor of Medicine, University of Texas MD Anderson Cancer Research Center
Yufang Shi, PhD
Director, Institutes for Translational Medicine
13:00
- 14:30
Process Validation 101 (ISCT-FACT Quality Bootcamp)
Director BMT Laboratory,Sydney Children’s Hospital and Prince of Wales Hospital, Australia
Annette Trickett, PhD
Director BMT Laboratory,Sydney Children’s Hospital and Prince of Wales Hospital, Australia
14:30
- 14:45
Coffee Break
14:45
- 16:15
Post-Infusion to Commercialization (Cell Processing Track)
Mara Neal, SH(ASCP)MT, MS, MBA
Director, Cook Regentec
Vicki Antonenas, BSc, MSc
Scientific Director, Westmead Hospital
Haematologist and Blood and Marrow Transplant Physician, Westmead Hospital, Australia
Kenneth P. Micklethwaite, MBBS, PhD, FRACP, FRCPA
Haematologist and Blood and Marrow Transplant Physician, Westmead Hospital, Australia
Virginia Litwin, PhD
Vice President, Immunology, Caprion Biosciences Inc., Canada
Barbara and Edward Netter Professor in Cancer Gene Therapy, University of Pennsylvania, USA
Bruce Levine, PhD
Barbara and Edward Netter Professor in Cancer Gene Therapy, University of Pennsylvania, USA
14:45
- 16:15
Doing Business in Korea
So Ra Park, MD, PhD
Secretary General, Council for Advanced Regenerative Medicine (CARM)
Professor & Head of Gene and Stem Cell Therapy Program, University of Sydney, Australia
John Rasko, AO, BSc(Med), MBBS(Hons), PhD
Professor & Head of Gene and Stem Cell Therapy Program, University of Sydney, Australia
In-Taek Lim
Director General, Bureau of Health Industry, MoHW
Sung hyun Choi
Project Leader (PL), Daewoong Co., Ltd
Nam Ho Kim
Researcher, Biosolution co., Ltd.
Donghoon Oh
Chief Scientific Officer, STEMLAB, Inc.
San U. Song
Founder and Chief Scientific Officer, SCM Lifescience Co. Ltd
Jooyoun Lee
President of R&D Center, Xcell Therapeutics
Jong Seong Ahn
Research Center Director, Green Cross Cell corp.
Gunsoo Kim
Chief Executive Officer, Curocell Inc.
14:45
- 15:45
Regulatory Convergence: Where we are and what we are up to? (Global Regulatory Perspectives)
Karen Nichols, Esq.
VP, Magenta Therapeutics
Judith Arcidiacono, MS
Regulatory Scientist, FDA, USA
Head, Advanced Therapy Products Unit, Health Sciences Authority, Singapore
Srinivasan Kellathur, PhD
Head, Advanced Therapy Products Unit, Health Sciences Authority, Singapore
Francesco Cicirello, PharmD (GPhC, FOPH), MSc
Inspector, Therapeutic Goods Administration
14:45
- 16:15
Evaluating and Reporting Audit Results (ISCT-FACT Quality Bootcamp)
14:45
- 16:15
Clinical Trials Part III: Characterization and Future Perspectives (MSC Workshop)
Donald Phinney, PhD
Professor, The Scripps Research Institute, Scripps Florida, USA
Luis Ortiz, PhD
Professor, University of Pittsburgh
Professor and Chair, Department of Anatomy & Cell Biology, University of Pennsylvania
Songtao Shi, DDS, MS, PhD
Professor and Chair, Department of Anatomy & Cell Biology, University of Pennsylvania
Yufang Shi, PhD
Director, Institutes for Translational Medicine
14:45
- 16:15
Cord Blood Derived MSCs, Exosomes, and Regenerative Medicine (Cord Blood Series)
Elizabeth J. Shpall, MD
Professor of Medicine, MD Anderson Cancer Center
Willem E. Fibbe, MD, PhD
Professor, Leiden University Medical Center
Helen E. Heslop, MD
Professor of Medicine and Pediatrics, Baylor College of Medicine
16:30
- 18:30
Cutting-Edge Manufacturing Solutions for Advanced Cell Therapies (Corporate Symposium Hosted By Miltenyi Biotec)
Professor & Head of Gene and Stem Cell Therapy Program, University of Sydney, Australia
John Rasko, AO, BSc(Med), MBBS(Hons), PhD
Professor & Head of Gene and Stem Cell Therapy Program, University of Sydney, Australia
Amit Chandra, PhD
Innovation Supervisor Cell Therapy, Yposkesi SAS, France
Founder, Chairman, and CSO, PersonGen BioTherapeutics (Suzhou) Co., Ltd., China
Lin Yang, Prof., PhD
Founder, Chairman, and CSO, PersonGen BioTherapeutics (Suzhou) Co., Ltd., China
Director, Stem Cell Transplant and Hematologic Malignancies, University Hospitals Cleveland Medical Center, USA
Marcos de Lima, Prof., MD
Director, Stem Cell Transplant and Hematologic Malignancies, University Hospitals Cleveland Medical Center, USA
19:00
- 21:30
ISCT 2019 President’s Welcome Address and Exhibit Open House Reception
19:45
- 20:00
Establishing the CCRM Model in Australia and Beyond: Opportunities and Challenges (ISCT Global Showcase Opening Address Hosted by CCRM)
Michael May, PhD
President and CEO, CCRM, Canada
Thursday
2019-05-30
Plenary Hall
Room 212
Room 220
Room 213
Room 219
Offsite
Poster Hall
Exhibit Hall
Room 217
ISCT Global Showcase Lounge
07:30
- 08:30
Overcoming Challenges in Cell Therapy Manufacturing (Corporate Breakfast Tutorial Hosted By Thermo Fisher Scientific)
Randy Schweickart
Director of Engineering, Juno Therapeutics, Inc
Tia Hexom
Field Applications Scientist, Thermo Fisher Scientific
07:30
- 08:30
Hot Topic Session 1 – Bioengineering of the GI Tract
Associate Professor in Gastroenterology, University of Verona School of Medicine, Italy
Rachele Ciccocioppo, MD
Associate Professor in Gastroenterology, University of Verona School of Medicine, Italy
Tracy Grikscheit, MD
Attending Physician, Children's Hospital of Los Angeles, United States
Giuseppe Orlando, MD, PhD
Assistant Professor, Wake Forest University Baptist Medical Center, USA
07:30
- 08:30
Hot Topic Session 2 – Getting to the Truth – Designing Studies and Clinical Network for Objective Evaluation of Cellular Therapies for Osteoarthritis of the Knee
George Muschler, MD
Orthopaedic Surgeon, Cleveland Clinic, United States
Nakamura Norimasa, MD, PhD
Professor, Osaka Health Science University, Japan
Research Director, Inserm Institute for Regenerative Medicine and Biotherapies, France
Danièle Noël, PhD
Research Director, Inserm Institute for Regenerative Medicine and Biotherapies, France
Constance Chu, MD
Professor of Orthopaedic Surgery, Stanford University School of Medicine, USA
07:30
- 08:30
Commercial, Manufacturing and Clinical Aspects of a Multinational Rare Disease Gene Therapy Trial (Corporate Breakfast Tutorial Hosted by Cell Therapies Pty Ltd)
Nathan Smith
Project Portfolio Manager, Cell Therapies Pty Ltd, Australia
Geoff Mackay
Chief Executive Officer, AvroBio, USA
Alexandra Rizzitelli, PhD
Cell Therapy Specialist, Cell Therapies Pty Ltd, Australia
Haematologist & Head of Allogeneic Stem Cell Transplantation, The Royal Melbourne Hospital, Australia
David Ritchie, Prof., MD, PhD
Haematologist & Head of Allogeneic Stem Cell Transplantation, The Royal Melbourne Hospital, Australia
08:30
- 09:00
Opening Remarks, 2019 Cell Therapy Training Course Scholars Announcement, Presentation of 2019 Career Achievement Award in Cellular Therapy to John Barrett, MD, FRCP, FRCPath
09:00
- 10:30
Presidential Plenary: CAR-Ts Beyond B Cells
Professor & Head of Gene and Stem Cell Therapy Program, University of Sydney, Australia
John Rasko, AO, BSc(Med), MBBS(Hons), PhD
Professor & Head of Gene and Stem Cell Therapy Program, University of Sydney, Australia
Saar Gill, MD, PhD
Assistant Professor, University of Pennsylvania, Philadelphia, USA
Weidong Han, MD, PhD
Professor, Chinese PLA General Hospital, China
Full Professor of Pediatrics, University of Pavia/IRCCS Ospedale Pediatrico Bambino Gesù, Italy
Franco Locatelli, MD, PhD
Full Professor of Pediatrics, University of Pavia/IRCCS Ospedale Pediatrico Bambino Gesù, Italy
10:30
- 11:00
Coffee Break
10:30
- 10:45
Solutions That Enable Efficiencies in cGMP Manufacturing (Global Showcase Presentation Hosted By GE Healthcare)
Greg Crescenzi
Enterprise Solutions Leader, GEHC Cell and Gene Therapy
10:45
- 11:00
Engineered for Life – BIOSTAT® RM TX with FLEXSAFE® RM TX for Culturing Consistent Quality Cellular Products (Global Showcase Presentation Hosted By Sartorius Stedim Biotech)
Ruth McDermott
Platform Manager Regenerative Medicine, Sartorius Stedim Biotech, UK
11:00
- 12:15
Advanced Practice Professionals (APP track) Session 1 – Cord-Blood Derived Therapies for Regenerative Medicine, Transplantation & Cancer Immunotherapy
Megan Cornelison, MS, PA-C
MD Anderson Cancer Center
Tobi Fisher, MPAS, PA-C
MD Anderson Cancer Center
Attending Physician, Memorial Sloan Kettering Cancer Center, New York, USA
Juliet Barker, MBBS, FRACP
Attending Physician, Memorial Sloan Kettering Cancer Center, New York, USA
Ngaire Elwood, PhD
Director, BMDI Cord Blood Bank, Australia
David DiGiusto, PhD
Chief Technical Officer, Semma Therapeutics, United States
11:00
- 12:15
Regulatory Spotlight – Clinical Site Cell Supply for Commercial CAR-T Products – How to Integrate Regional Rules and Policies into Global Networks
Simon Harrison, MBBS, PhD
Director of Clinical Aphaeresis, Peter MacCallum Cancer Centre, Australia
Francesco Cicirello, PharmD (GPhC, FOPH), MSc
Inspector, Therapeutic Goods Administration
Bryan Silvey
Kite, A Gilead Company
Peter Holman, MS
Novartis, United States
11:00
- 12:15
Strategies for Commercialization Track Session 1 – Think Big and Think Early to Prevent Failure at Commercial Scale
Simon Ellison, MBA
Service Director, Cell and Gene Therapy, World Courier, United Kingdom
Heidi Hagen, MS, MBA
Co-Founder & Chief Strategy Officer Vineti, Inc, USA
Kilian Kelly, PhD
Vice President, Product Development, Cynata Therapeutics, Australia
Andrew McDonald
Director, Australia & New Zealand, World Courier, Australia
Robin Ng, PhD
Strategy Lead, Technology & Manufacturing, Cellular Biomedicine Group, China
11:00
- 12:15
Plenary 2 Satellite Session – Enabling Technologies in Regenerative Medicine
Tracy Grikscheit, MD
Attending Physician, Children's Hospital of Los Angeles, United States
Jessica Frith, PhD
Monash University, Australia
11:00
- 12:15
Plenary 1 Satellite Session – Immunotherapy Oral Abstract Presentations I
Saar Gill, MD, PhD
Assistant Professor, University of Pennsylvania, Philadelphia, USA
David Bishop, MBBS
Haematologist, Westmead Institute for Medical Research, Australia
Patrick Hanley, PhD
Director, GMP for Immunotherapy Children's National Medical Center, USA
11:00
- 12:15
Quality and Operations Track Session 1 – Emerging Standards in Cell & Gene Therapies
Affiliate Scientist, Cell Therapy Program, University Health Network, Canada
Sowmya Viswanathan, PhD
Affiliate Scientist, Cell Therapy Program, University Health Network, Canada
Judith Arcidiacono, MS
Regulatory Scientist, FDA, USA
Brian Hawkins, PhD
Chief Technology Officer, Pluristyx, Inc., USA
Director, Cell GMP Facility, University of North Carolina Chapel-Hill, United States
Paul Eldridge, PhD
Director, Cell GMP Facility, University of North Carolina Chapel-Hill, United States
12:15
- 13:45
Lunch with Exhibits
12:30
- 12:45
Beyond Blood – Supporting Cell Therapies From the Bottom Up (Global Showcase Presentation Hosted By Australian Red Cross Blood Service)
Shane Winzar
Australian Red Cross Blood Service, Australia
Augustin Raj
Australian Red Cross Blood Service, Australia
12:30
- 13:30
Driving Speed to Market Through Collaboration (Corporate Tutorial Hosted by GE Healthcare)
Phil Vanek, PhD
GM, Growth Strategy, GEHC Cell and Gene Therapy, USA
Robin Ng, PhD
Strategy Lead, Technology & Manufacturing, Cellular Biomedicine Group, China
Rohin Iyer, PhD
Development Manager, Cell and Gene Therapy, GEHC/FASTTrak@CCRM
Greg Crescenzi
Enterprise Solutions Leader, GEHC Cell and Gene Therapy
12:45
- 13:00
Regeneus’ Novel Allogenic Stem Cell Platforms for Musculoskeletal and Neuropathic Pain Disorders (Global Showcase Presentation Hosted By Regeneus Ltd)
Charlotte Morgan, PhD
Head of R&D, Regeneus, Australia
13:00
- 13:15
HPL Pathogen Reduction Treatment and Risk Assessment (Global Showcase Presentation Hosted By AventaCell Biomedical)
Bill Milligan
SVP Corporate Development & Business Development, Steminent Biotherapeutics, Canada
13:15
- 13:30
Fast Forward to hMSC Manufacturing: A Novel, Xeno-Free Medium Supporting Planar Suspension Formats for Easy Scale-Up (Global Showcase Presentation Hosted By Merck)
Head of Biomaterials and Assays, Cell Therapy Bioprocessing, Merck, United States
Kathleen Ongena, PhD
Head of Biomaterials and Assays, Cell Therapy Bioprocessing, Merck, United States
13:45
- 15:15
Plenary Session 2 – Complex Cellular Structures: Realising The Regenerative Potential of Cells
Oscar K. Lee, MD, PhD
Chair Professor, National Yang-Ming University, Taiwan
Janet Macpherson, PhD
Product Sales Specialist, Cell & Gene Therapy, GE Healthcare, Australia
Theme Director of Cell Biology, Murdoch Children's Research Institute, Australia
Melissa Little, PhD
Theme Director of Cell Biology, Murdoch Children's Research Institute, Australia
Yoshiki Sawa, MD, PhD
Professor, Osaka University, Japan
Tracy Grikscheit, MD
Attending Physician, Children's Hospital of Los Angeles, United States
15:15
- 15:45
Coffee Break
15:15
- 15:30
Industrializing Cell and Gene Therapy: Upstream Technologies (Global Showcase Presentation Hosted By Pall Biotech)
Seunghoon Choe, BSc., Meng
Bioprocess Applications Specialist, Pall Biotech, South Korea
15:30
- 15:45
A Novel, Single-Use Bioreactor System for Expansion of Human Mesenchymal Stem/Stromal Cell (Global Showcase Presentation Hosted by Pall Biotech)
Kaitlynn Bayne
Associate Scientist, Pall Biotech, United States
15:45
- 17:00
Plenary 2 Satellite Session – Organoids for Regenerative Medicine
Theme Director of Cell Biology, Murdoch Children's Research Institute, Australia
Melissa Little, PhD
Theme Director of Cell Biology, Murdoch Children's Research Institute, Australia
Gay Crooks, MBBS
Professor, University of California Los Angeles, United States
David Elliott, PhD
Team Leader, Murdoch Children's Research Institute
15:45
- 17:00
Quality and Operations Track Session 2 – Applied Risk Assessment
Gerry McKiernan, BSc
Quality Manager, Cell Therapies Pty Ltd, Australia
